China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.13
-0.18 (-2.11%)
Sep 18, 2026, 4:08 PM HKT

HKG:2877 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7,5387,1896,1405,8895,0264,206
Short-Term Investments
-5.774.484.023.694.32
Trading Asset Securities
-376.64350.022020.23-
Cash & Short-Term Investments
7,5387,5716,4955,9135,0504,210
Cash Growth
8.29%16.58%9.84%17.08%19.96%6.63%
Accounts Receivable
840.171,0001,2021,260975.06825.18
Other Receivables
5.9724.866.8163.9267.4840.87
Receivables
846.141,0251,2691,3241,043866.05
Inventory
562.51691.3813.19897.71657.66587.96
Other Current Assets
58.5316.592219.9432.0135.06
Total Current Assets
9,0069,3048,5998,1556,7825,699
Property, Plant & Equipment
1,2361,2491,2191,2051,2171,252
Goodwill
165.96165.96165.96165.96165.96165.96
Other Intangible Assets
12.3715.7223.3232.7947.3566.43
Long-Term Deferred Tax Assets
35.6542.734.3315.2319.2220.47
Total Assets
10,45510,77710,0429,5748,2327,204

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
246.98340.03402.96484.79308.75228.62
Accrued Expenses
-1,1901,1991,121856.76483.21
Short-Term Debt
306.95325.05330300--
Current Portion of Leases
4.819.068.270.976.537.59
Current Income Taxes Payable
15.1660.2284.27105.91107.7965.1
Current Unearned Revenue
138.33221.86101.75127.4165.22117.05
Other Current Liabilities
1,375364.28323.67294.13220.54196.81
Total Current Liabilities
2,0872,5102,4502,4341,6661,098
Long-Term Leases
0.530.798.260.360.917.32
Long-Term Unearned Revenue
113.68106.2481.8588.89163.99171.59
Long-Term Deferred Tax Liabilities
48.0498.0234.5216.2618.8425.19
Total Liabilities
2,2492,7152,5752,5391,8491,302

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
87.6687.6687.6687.6687.6687.66
Additional Paid-In Capital
-422.14422.14422.14422.14422.14
Retained Earnings
-8,0477,4527,0206,3685,879
Comprehensive Income & Other
8,118-494.89-494.89-494.89-494.89-487.32
Shareholders' Equity
8,2068,0627,4677,0356,3835,901
Total Liabilities & Equity
10,45510,77710,0429,5748,2327,204

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
312.29334.9346.53301.337.4414.91
Net Cash (Debt)
7,2267,2376,1485,6115,0434,195
Net Cash Growth
9.16%17.70%9.56%11.28%20.21%17.97%
Net Cash Per Share
9.589.588.147.436.685.56
Filing Date Shares Outstanding
756.71755.4755.4755.4755.4755.4
Total Common Shares Outstanding
756.71755.4755.4755.4755.4755.4
Working Capital
6,9196,7946,1495,7215,1174,601
Book Value Per Share
10.8410.679.889.318.457.81
Tangible Book Value
8,0287,8807,2786,8366,1695,669
Tangible Book Value Per Share
10.6110.439.639.058.177.50
Machinery
-2,7412,7981,4891,4381,392
Construction In Progress
-335.57195.51117.68193.06130.17